November 13, 2013
Eli Lilly & Co. and other drugmakers on Tuesday urged the Sixth Circuit to deny an appeal by plaintiffs seeking to hold them liable for injuries allegedly tied to generic versions of the painkillers Darvocet and Darvon, saying brand-name manufacturers have no legal duty to generics consumers.